| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |